Reviewing COLLPLANT HOLDI/S (CLGN) & Its Peers

Share on StockTwits

COLLPLANT HOLDI/S (NASDAQ: CLGN) is one of 27 public companies in the “Surgical appliances & supplies” industry, but how does it contrast to its peers? We will compare COLLPLANT HOLDI/S to related businesses based on the strength of its analyst recommendations, dividends, profitability, institutional ownership, risk, valuation and earnings.

Analyst Ratings

This is a breakdown of current ratings and target prices for COLLPLANT HOLDI/S and its peers, as provided by

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
COLLPLANT HOLDI/S Competitors 172 816 1439 73 2.57

As a group, “Surgical appliances & supplies” companies have a potential upside of 17.25%. Given COLLPLANT HOLDI/S’s peers higher probable upside, analysts plainly believe COLLPLANT HOLDI/S has less favorable growth aspects than its peers.

Earnings and Valuation

This table compares COLLPLANT HOLDI/S and its peers revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
COLLPLANT HOLDI/S $480,000.00 -$6.02 million -2.45
COLLPLANT HOLDI/S Competitors $1.30 billion $195.91 million 23.18

COLLPLANT HOLDI/S’s peers have higher revenue and earnings than COLLPLANT HOLDI/S. COLLPLANT HOLDI/S is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Institutional & Insider Ownership

58.0% of shares of all “Surgical appliances & supplies” companies are held by institutional investors. 9.9% of shares of all “Surgical appliances & supplies” companies are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.


This table compares COLLPLANT HOLDI/S and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
COLLPLANT HOLDI/S -552.97% -80.17% -41.81%
COLLPLANT HOLDI/S Competitors -184.55% -204.58% -24.01%


COLLPLANT HOLDI/S peers beat COLLPLANT HOLDI/S on 8 of the 9 factors compared.


CollPlant Holdings Ltd., a regenerative medicine company, focuses on developing and commercializing tissue repair products for three-dimensional (3D) bio-printing of tissues and organs, orthobiologics, and advanced wound care markets in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen (rhCollagen) that is produced with its proprietary plant based genetic engineering technology. The company's products include Vergenix STR, a soft tissue repair matrix intended for treatment of tendinopathy; Vergenix FG, a wound-filling flowable gel for the treatment of deep surgical incisions and wounds, including diabetic ulcers, venous and pressure ulcers, burns, bedsores, and other chronic wounds; and BioInks for 3D printing of tissues and organs. CollPlant Holdings Ltd. and is headquartered in Ness Ziona, Israel.

Receive News & Ratings for COLLPLANT HOLDI/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for COLLPLANT HOLDI/S and related companies with's FREE daily email newsletter.

Leave a Reply